Hydra Biosciences
Hydra Biosciences, biopharmaceutical company, Cambridge, Massachusetts, novel drugs important human diseases, major therapeutic areas, pain, cardiovascular disease, transient receptor potential (TRP) ion channels, molecular regeneration..
Employees
Enterprise value
$42—63m
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
| N/A | €0.0 | round | |
| investor investor investor investor | €0.0 | round | |
| investor investor investor investor investor investor | €0.0 | round | |
| investor investor investor investor investor | €0.0 | round | |
| investor | €0.0 | round | |
$10.5m | Series E | ||
| Total Funding | 000k | ||
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.